GLP-1 receptor agonist drugs, including Ozempic and Wegovy, promote earlier satiety to suppress appetite

Drug pricing and affordability, FDA drug approvals, clinical trial design, drug shortages, insurer coverage, pharmaceutical regulation, and medication access.

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.